Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.009 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |